HPCM
WST icon

Hunter Perkins Capital Management’s West Pharmaceutical WST Stock Holding History

Hunter Perkins Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
647
-345
-35% -$105K 0.05% 137
2026
Q1 		$249K Buy
+992
New +$247K 0.06% 129

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Hunter Perkins Capital Management's WST Position: Q2 2026 in Review

Hunter Perkins Capital Management reduced its West Pharmaceutical (WST) stake by 35% in Q2 2026, selling an estimated $105K and leaving 647 shares worth $232K. The position accounts for 0.05% of the portfolio, ranked #137.

Hunter Perkins Capital Management first reported a position in WST in Q1 2026 and has held it in 2 quarters since. The position peaked at $249K in Q1 2026. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Hunter Perkins Capital Management held 647 shares of West Pharmaceutical worth $232K as of Q2 2026.
  • Hunter Perkins Capital Management sold 345 West Pharmaceutical shares in Q2 2026, an estimated $105K.
  • West Pharmaceutical made up 0.05% of Hunter Perkins Capital Management's portfolio in Q2 2026, its #137 holding.
  • Hunter Perkins Capital Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • Hunter Perkins Capital Management's West Pharmaceutical position peaked at $249K in Q1 2026.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Hunter Perkins Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.